|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/498 | (2006.01) |
| A61K 31/498 | (2013.01) | ||
| A61K 31/7048 | (2006.01) | ||
| A61K 31/7048 | (2013.01) | ||
| A61P 17/00 | (2006.01) | ||
| A61P 17/00 | (2018.01) |
| (11) | Number of the document | 3377063 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16798698.3 |
| Date of filing the European patent application | 2016-11-17 | |
| (97) | Date of publication of the European application | 2018-09-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2016/078076 |
| Date | 2016-11-17 |
| (87) | Number | WO 2017/085226 |
| Date | 2017-05-26 |
| (30) | Number | Date | Country code |
| 15306822 | 2015-11-17 | EP |
| (72) |
MARTEL, Philippe , FR
KERROUCHE, Nabil , FR
AUDIBERT, Fabien , FR
|
| (73) |
Galderma S.A. ,
Zugerstrasse 8, 6330 Cham,
CH
|
| (54) | USE OF IVERMECTIN AND BRIMONIDINE IN THE TREATMENT AND/OR PREVENTION OF MODERATE TO SEVERE ROSACEA |
| USE OF IVERMECTIN AND BRIMONIDINE IN THE TREATMENT AND/OR PREVENTION OF MODERATE TO SEVERE ROSACEA |